Sex | Age group | Number of patients | One-year survival | Five-year survival | ||||
---|---|---|---|---|---|---|---|---|
 |  |  | % | 95% CI | % | 95% CI | ||
Men | Age-standardised | 91,876 | 79.4 | 79.2 | 79.7 | 60.8 | 60.3 | 61.3 |
 | Un-standardised | 91,876 | 77.7 | 77.4 | 78 | 59.4 | 58.9 | 60.0 |
 | 15–44 | 2887 | 87.6 | 86.4 | 88.8 | 70.7 | 68.6 | 72.8 |
 | 45–54 | 6214 | 86 | 85.1 | 86.8 | 63.4 | 61.9 | 64.9 |
 | 55–64 | 17,462 | 85.8 | 85.2 | 86.3 | 67.2 | 66.3 | 68.1 |
 | 65–74 | 28,572 | 82.7 | 82.2 | 83.1 | 66.1 | 65.3 | 66.9 |
 | 75–99 | 36,741 | 67.9 | 67.4 | 68.5 | 49 | 48 | 50.1 |
Women | Age-standardised | 73,104 | 77.3 | 77 | 77.6 | 60.1 | 59.6 | 60.6 |
 | Un-standardised | 73,104 | 73.7 | 73.4 | 74 | 57 | 56.5 | 57.6 |
 | 15–44 | 2966 | 88.7 | 87.5 | 89.8 | 71.3 | 69.3 | 73.3 |
 | 45–54 | 5250 | 86.7 | 85.7 | 87.6 | 66.5 | 64.9 | 68.1 |
 | 55–64 | 11,617 | 86 | 85.3 | 86.6 | 67.9 | 66.8 | 69 |
 | 65–74 | 18,637 | 81.3 | 80.7 | 81.9 | 65.1 | 64.2 | 66.1 |
 | 75–99 | 34,634 | 62.3 | 61.7 | 62.8 | 46.4 | 45.5 | 47.3 |